Corteva (NYSE:CTVA) PT Raised to $65.00 at Deutsche Bank Aktiengesellschaft

Corteva (NYSE:CTVA) had its price target raised by equities research analysts at Deutsche Bank Aktiengesellschaft from $62.00 to $65.00 in a report released on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 13.00% from the company’s current price.

A number of other research analysts also recently commented on the company. BMO Capital Markets increased their target price on Corteva from $64.00 to $67.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Barclays lifted their price objective on shares of Corteva from $55.00 to $58.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 10th. Royal Bank of Canada increased their target price on shares of Corteva from $56.00 to $64.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. TheStreet raised shares of Corteva from a “c+” rating to a “b-” rating in a report on Tuesday, February 27th. Finally, BNP Paribas upgraded shares of Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 price objective on the stock in a research note on Friday, February 2nd. Six equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $63.24.

Corteva Stock Performance

Shares of CTVA opened at $57.52 on Monday. The firm has a market cap of $40.09 billion, a price-to-earnings ratio of 72.81, a PEG ratio of 1.50 and a beta of 0.78. The company has a quick ratio of 0.97, a current ratio of 1.51 and a debt-to-equity ratio of 0.10. The business’s 50 day moving average is $55.45 and its two-hundred day moving average is $50.74. Corteva has a 52-week low of $43.22 and a 52-week high of $59.04.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, May 1st. The company reported $0.89 EPS for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. The firm had revenue of $4.49 billion for the quarter, compared to the consensus estimate of $4.65 billion. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The firm’s revenue was down 8.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.16 EPS. Analysts forecast that Corteva will post 2.83 EPS for the current fiscal year.

Institutional Investors Weigh In On Corteva

Large investors have recently made changes to their positions in the company. CVA Family Office LLC purchased a new position in Corteva during the 4th quarter worth approximately $25,000. Redmont Wealth Advisors LLC acquired a new stake in shares of Corteva in the first quarter worth $25,000. BKM Wealth Management LLC purchased a new position in shares of Corteva during the fourth quarter valued at $27,000. Rise Advisors LLC raised its position in Corteva by 2,522.2% during the first quarter. Rise Advisors LLC now owns 472 shares of the company’s stock valued at $27,000 after buying an additional 454 shares during the period. Finally, NewSquare Capital LLC lifted its stake in Corteva by 70.6% in the 3rd quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock worth $28,000 after acquiring an additional 226 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.